Trials / Completed
CompletedNCT02782169
Prophylactic Pregabalin to Decrease Pain During Medical Abortion
Prophylactic Pregabalin to Decrease Pain During Medical Abortion: a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- University of Hawaii · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Medical abortion has been associated with significant pain. The objective of this trial is to determine whether one dose of pregabalin 300 mg, given during medical abortion in addition to the standard of care analgesics, will decrease experienced pain. Investigators will perform a randomized, double-blinded, placebo-controlled trial. Participant pain levels and side effects will be assessed at multiple time points, along with a measure of satisfaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin | Pregabalin 300 mg capsule (over encapsulated to maintain blinding) |
| DRUG | Placebo | Matching placebo capsule with excipient to match Pregabalin |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2016-10-01
- Completion
- 2016-12-01
- First posted
- 2016-05-25
- Last updated
- 2018-04-19
- Results posted
- 2018-04-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02782169. Inclusion in this directory is not an endorsement.